Indivior PLC (OTCMKTS:INVVY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares.
Indivior Stock Down 1.8%
The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of 20.81 and a beta of 0.35. The stock’s fifty day moving average price is $21.85 and its 200-day moving average price is $21.85.
About Indivior
Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing treatments for addiction and related disorders. The company’s core business centers on addressing opioid use disorder through a portfolio of branded pharmaceuticals and delivery systems designed to support long-term recovery. Indivior’s therapies are aimed at improving patient outcomes by reducing withdrawal symptoms and lowering the risk of relapse.
The company’s flagship product, Suboxone®, is a buprenorphine-naloxone sublingual film approved for the treatment of opioid dependence.
Featured Stories
- Five stocks we like better than Indivior
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
